TF3P: Three-dimensional Force Fields Fingerprint Learned by Deep
  Capsular Network by Wang, Yanxing et al.
TF3P: A New Three-dimensional Force Fields Fingerprint
Learned by Deep Capsular Network
Yanxing Wang†,1, Jianxing Hu†,1, Junyong Lai1, Yibo Li2, Hongwei Jin1, Lihe Zhang1, Liang-Ren
Zhang*,1, Zhen-ming Liu*,1
1: State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences,
Peking University, Beijing, 100191, P. R. China
2: Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, 100191, P. R. China
†: These authors contributed equally.
*: To whom correspondence should be addressed.
Author Email Address:
Yanxing Wang: yh_wang@bjmu.edu.cn;
Jianxing Hu: j.hu@pku.edu.cn;
Junyong Lai: jylai@bjmu.edu.cn;
Yibo Li: ybli@pku.edu.cn;
Hongwei Jin: jinhw@bjmu.edu.cn;
Lihe Zhang: zdszlh@bjmu.edu.cn;
Liang-Ren Zhang: liangren@bjmu.edu.cn;
Zhen-ming Liu: zmliu@bjmu.edu.cn.
Abstract:
Molecular fingerprints are the workhorse in ligand-based drug discovery. In recent years, an increasing
number of research papers reported fascinating results on using deep neural networks to learn 2D
molecular representations as fingerprints. It is anticipated that the integration of deep learning would
also contribute to the prosperity of 3D fingerprints. Here, we unprecedentedly introduce deep learning
into 3D small molecule fingerprints, presenting a new one we termed as the three-dimensional force
fields fingerprint (TF3P). TF3P is learned by a deep capsular network whose training is in no need
of labeled datasets for specific predictive tasks. TF3P can encode the 3D force fields information
of molecules and demonstrates the stronger ability to capture 3D structural changes, to recognize
molecules alike in 3D but not in 2D, and to identify similar targets inaccessible by other 2D or 3D
fingerprints based on only ligands similarity. Furthermore, TF3P is compatible with both statistical
models (e.g. similarity ensemble approach) and machine learning models. Altogether, we report
TF3P as a new 3D small molecule fingerprint with a promising future in ligand-based drug discovery.
All codes are written in Python and available at https://github.com/canisw/tf3p.
Keywords: Deep Learning; Capsular Network; 3D Molecular Fingerprint; Force Fields; Ligand-based
Target Prediction.
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Introduction
It is a primary principle in ligand-based drug discovery that similar ligands bind to similar targets1.
This statement, in essence, is to infer target similarity from only ligand information. Over the past
decades of endeavor to improve this inference with more precision, molecular representation is a
useful tool2-5 and can be divided intuitively into two categories, namely 2D and 3D representations.
Since the 1970s, 2D molecular fingerprints have been developed maturely and can be classified into four
types3, namely substructure keys (e.g. MACCSKey6), circular fingerprints (e.g. ECFP7), topological
fingerprints (e.g. atom pairs8, topological torsions9, Avalon fingerprint10) and pharmacophores. In
addition to these classical molecular fingerprints designed by chemists, with the advent of deep
learning in recent years, an increasing number of research papers reported on using deep neural
networks (DNN) to fingerprint 2D molecules11-17. Of particular note is the recent Attentive FP15
which achieves the state-of-art performance on several datasets in the field of ligand-based bioactivity
prediction.
Compared to 2D representation, using molecular 3D representation18 is expected to enhance the
performance of predictive models, especially in the prediction of biological targets for small molecule
drugs. USR/USRCAT19, 20 is moment-based molecular 3D representations that encode molecular
shape (and color for USRCAT). E3FP21, as another 3D molecular fingerprint, was inspired by ECFP
and presents higher precision-recall performance than ECFP when integrated with the similarity
ensemble approach (SEA)22. Besides the above rotation and translation invariant fingerprints,
Gaussian-based representation (used in ROCS23 and SimG24) is another example that strengthens
this argument. When it further comes to voxelized representation25, 26, it is a common practice to
integrate this representation with supervised convolutional DNN and promising results have been
demonstrated on the prediction of the biological target or binding affinity for small molecules27-32.
Despite all the above, there is no 3D fingerprint learned by DNN reported thus far.
Whereas 2D molecular fingerprints generated by DNN showed excellent ability in many predictive
models, most of them reported up to now have two flaws: i) Such fingerprinting models need
individual training for each predictive tasks, resulting in that none of generated fingerprints contain
the unbiased information within an intact molecule; ii) Similarity calculation of such fingerprints
is a complication to their compatibility with similarity-based statistical models such as SEA22. In
2019, Winter et al. introduced a DNN-based translation model between two equivalent chemical
representations (e.g. IUPAC name and SMILES) to deal with these two flaws33. While this model
can be trained as a general fingerprinter with such chemical representations and simultaneously
nine more molecular properties (i.e. log P, etc.), the fact that the generated representation must
be normalized over the dataset of interest before similarity calculation defines its deficiency. Our
research presented here is also aimed to overcome these limitations and further push forward with
the neural network to fingerprint 3D molecules.
Fingerprinting 3D molecule is to encode 3D object. We can learn a lot about the encoding method
from computer graphics. Hinton et al. recently introduced CapsNet34-36 to learn to output the
pose matrix of 3D objects, which can be intuitively interpreted as the orientation and position of
objects in 3D space. The idea behind CapsNet is to surmount one deficiency of the convolutional
neural network (CNN), as shown in Figure 1. Each capsule in CapsNet is capable to learn the
instantiation parameters (i.e. values for orientation, size, etc.) of each feature and output a vector
with its length as the possibility indicating the presence of that feature. Taken all features together,
CapsNet outputs a matrix that represents the input. It is worth noting that capsules do not guarantee
provable rotation/translation equi-/in-variance intrinsically. In 2018 and late 2019, P. Libuschewski
et al.37 and R. R. Sarma et al.38 advanced the equivariance of capsular networks, but there is still no
remedy for invariance.
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Figure 1. The CNN cannot detect relationships between features and then fails to detect deformed
samples, but CapsNet can.
In this paper, we construct a deep capsular neural network to fingerprint 3D small molecule, which
can be trained without targeting specific predictive tasks. Molecular force fields grids, as a kind of
voxelized representation employed in 3D field-based QSAR39, 40, were adopted as the inputs of our
neural network. This was in the very consideration that one intended application of our fingerprint
is ligand-based target prediction and that the binding of small molecules to biological targets is
dominated by physical forces. All in all, molecular force fields grids can be compressed with the
well-trained model into a real-valued matrix, termed as the three-dimensional force fields fingerprint
(TF3P). We further demonstrated TF3P’s strong ability to capture 3D structural changes and
recognize similar targets which are inaccessible by other fingerprints based on only ligands similarity.
Additionally, TF3P is compatible with both statistical models and machine learning models.
Methods & Materials
Model Architecture
Our model is a modified version of CapsNet for 3D convolutions, composed of 15 layers. The first 8
layers are encoder and the last 7 layers are decoder. The overall architecture is shown in Figure 2.
Figure 2. The architecture of our model. The arrows indicate the data flow. TF3P: the three-
dimensional force fields fingerprint.
Inputs. Our model takes the force fields grids of a molecule’s conformer as inputs, which have
two channels, namely van der Waals potential and electrostatic potential. The grids calculation
is implemented using open source force field MMFF9441-45 in Python with alkyl carbon (MMF
type 1) and proton as probes without solvents for each channel, respectively. The box size is set to
20× 20× 20 A˚ so that it can hold common lead-like small molecule drugs. The grids’ size is set to
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50× 50× 50 points with a resolution of 0.4 A˚. In summary, the input tensor for each conformer has
the shape of 2× 50× 50× 50.
Encoder. This part of the network takes the input force fields grids and learns to encode them into a
166× 8 matrix as the fingerprint. The row vector dimension of 8 is chosen as the same value used
by Hinton et al. The encoder consists of six 3D convolutional layers and two capsular layers. The
convolutional layers serve as a feature extractor to reduce the sparse inputs’ dimension into a smaller
size suitable for the subsequent capsular layers since capsular layer has hundred times of trainable
parameters than convolutional layer under the same scale. Every convolutional layer has kernels
with a size of 3× 3× 3 and stride 1, followed by batch normalization and LeakyReLU activation.
Besides, in every two convolutional layers is inserted a max-pooling layer. After convolution, the
inputs’ shape is transformed into 128× 5× 5× 5. PrimaryCaps layer is in nature a convolutional
layer with its scalar outputs chunked into vectors and then squashed. The squashing function is the
novel non-linear activation function designed for capsules. DigitCaps layer receives input from all the
capsules in the PrimaryCaps layer with routing by agreement and produces a matrix with a size of
166× 8.
Decoder. The decoder part takes the outputs of DigitCaps, the fingerprint, to reconstruct the input
force fields grids. This part is used as a regularizer, whose job is to encourage the digit capsules to
encode the pose information into each digit. Therefore, we simply use a nearly symmetric architecture
consisting of a linear layer, transposed 3D convolutional layers with upsampling to decode the outputs
of DigitCaps.
Model Training
Our model was implemented with Pytorch 1.346 and trained with Adam47 optimizer. The learning
rate was set to 0.001, and all other parameters were default. The loss function we used was the same
as that of CapsNet, which has two parts: Margin loss and reconstruction loss.
Loss = margin_loss+ weight ∗ recontruction_loss
where the two decomposed losses use similar forms as Hinton et al.35:
margin_loss = 1
k
∑
k
Tk max
(
0, m+ − ‖vk‖
)2 + λ (1− Tk) max (0, ‖vk‖ −m−)2
reconstution_loss = MSE(inputs, reconstructions)
where k is digital capsule index; m+ = 0.9 and m− = 0.1; Tk = 1 if a digit of class k is present;
λ = 0.5. The margin loss here was calculated with 2D molecular fingerprints as labeled digit classes.
Both MACCSKey and ECFP4 were tested here for training. The final model for evaluation was
trained on 1% random samples of the full prepared data set (~ 3 million compounds, further explained
below) with MACCSKey over 10 epochs with a reconstruction weight of 0.005. All fingerprints were
calculated and stored for training in advance, but the force fields grids were calculated on the fly.
The training process for the final model took up to about one week on three NVIDIA TITAN RTX
GPUs.
Data set
ZINC15 48 3D lead-like (logP <= 3.5, 250 < MW < 500) subset was retrieved to train our model. A
total number of ~286 million molecules with pre-generated conformers were downloaded from the ZINC
database. Approximately 25 thousand molecules (less than 0.01%) that cannot be parameterized by
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the MMFF94 force field or cannot be sanitized by RDKit (v2019.09.2)49, 50 were filtered out and
excluded from the subsequent training process. However, given the huge calculation cost of force
fields grids and the large size of the full data set, not all these data were actually used in the study.
We randomly sampled various proportions of the full data set and split it randomly into a training
set and test set by 9:1 for model training.
ChEMBL25 51, 52 were retrieved for the evaluation. The distribution of the number of rotatable bonds
was analyzed for all molecules within ChEMBL25. For the assessment of fingerprints’ sensitivity
to 3D structural changes, 1000 molecules were randomly sampled for each number of rotatable
bonds ranging from 0 to 15. To obtain a relatively wide range of RMSD values, 100 conformers
were generated for each molecule, and then 1 conformer was selected as the reference and another
99 were aligned to the reference with RMSD calculated and ranked. Finally, 10 out of 99 were
selected with equal RMSD intervals from high to low and calculated similarities to the reference
with various fingerprints. Conformation generation and alignment were implemented with RDKit
(v2019.09.2)49, 50. RMSD was calculated using rmsdcalc utility from Schrodinger Suites 2018-153.
PDBbind v2018 General Set54 was retrieved for the evaluation. Only the complexes with pActivity
(pKd, pIC50, etc.) greater than 6 were kept as “active” samples and used subsequently. As a
conformation-dependent fingerprint without rotation invariance, ligand pairs need to be aligned
to each other before fingerprinting and similarity calculation. We investigated the performance
of our model in three situations: i) Query co-crystallized conformation aligned to co-crystallized
conformation (X2X) with RDKit; ii) Query low-energy conformation aligned to co-crystallized
conformation (LE2X) with RDKit; iii) Query flexibly aligned to co-crystallized conformation with
Omega55 and ROCS23. The first one was aimed to rule out bad effects resulting from conformation
sampling strategy; the latter two were designed to match the real target prediction scenario.
The dataset for solubility and malaria bioactivity prediction was benchmarked by Duvenaud et al.16
and Kearnes et al.17
Fingerprints calculation
Except that 166-bits ECFP4 was used only in the model training, 1024-bits one was utilized in
both training and all the evaluations. Both ECFP4 and MACCSKey were computed using RDKit.
1024-bits E3FP was computed using the default parameters and codes provided by the author in his
GitHub repo (https://github.com/keiserlab/e3fp-paper/tree/1.1/e3fp_paper). USR/USRCAT were
also evaluated in this study, calculated with RDKit.
Similarity calculation for two fingerprints
Tanimoto coefficient was used for MACCSKey, ECFP4, and E3FP. USRScore implemented in RDKit
was used for USR/USRCAT. As for real-valued TF3P, since it is a matrix of which each row vector
has its independent structural meaning, it is intuitive to calculate the similarity row-wisely. We
designed a weighted mean of the cosine similarity of each row vector to calculate the similarity
between two TF3Ps, M, N ∈RK×L, as the following form:
Sim = ( 12k
∑
k
((1− |mk − nk|) pk
mknk
+ 1))
3
where p,m,n ∈ RK , pk =
∑
lMklNkl, mk =
√∑
lM
2
kl, nk =
√∑
lN
2
kl.
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Results & Discussion
Training performance of models with different super parameters
As each digit represents a certain 2D structural feature, 2D fingerprints were used as digit class labels
during the training process. Under this circumstance, each digit capsule had to learn to output an
eight-dimensional vector containing the 3D force fields information in regard to each 2D structural
feature.
We first investigated what proportion and epochs for training could make a compromise between
model performance and time cost for training. As shown in Figure 3 A, the more data was fed into
the model, the lower did the loss value achieve. An interesting point is that the loss value decreases
to almost the same after the same amount of the total fed data, no matter what proportion of the full
dataset sampled. This indicates a great structural redundancy of the ZINC database. In summary,
1% of the full dataset (~ 3 million compounds) is sufficient for the convergence of the loss function
after 10 epochs of training with MACCSKey. The grid size (GS) and reconstruction weight (W )
were set to 50 and 0.005, respectively.
Figure 3. Training performance with different super parameters. A) The loss value of test set when
training with super parameters as MACCSKey-b166-GS50-W5. B) The decomposed loss values of
test set when training with indicated super parameters. b166/b1024, 166-bit/1024-bit version of
indicated fingerprint; GS50/GS64, grid size set as 50× 50× 50/64× 64× 64; W1/W5, reconstruction
set as 1/0.005. For loss curves of train/test set during training, see Figure S1.
After the optimal proportion and training epochs determined, we assessed how much the training
performance dependent on other super parameters of the model, i.e. W , GS, and 2D fingerprints.
As shown in Figure 3 B, increasing the W to 1 would make the reconstruction loss dominate the
margin loss during training (MACCSKey-b166-GS50-W5 vs. MACCSKey-b166-GS50-W1) but the
reconstruction is expected to play as a regularizer and less important than margin loss, which was
mentioned by Hinton et al.35 We next found that increasing GS to 64× 64× 64 contributed a lot to
the decrease of the reconstruction loss but a little to the margin loss (MACCSKey-b166-GS50-W5 vs.
MACCSKey-b166-GS64-W5). Furthermore, another fingerprint, ECFP4, was evaluated to show how
much different types of fingerprints impacted on the training performance. To make the results compa-
rable, two versions, i.e. 166-bit one and 1024-bit one, were included. Compared with MACCSKey, the
loss value convergent pretty slowly when training with 166-bit ECFP4 (MACCSKey-b166-GS50-W5 vs.
ECFP4-b166-GS50-W5), but 1024-bit version demonstrated comparable results with the model with
MACCSKey, GS = 64, and W = 0.005 (ECFP4-b1024-GS50-W5 vs. MACCSKey-b166-GS64-W5).
The capsular networks are often constrained by computation efficiency. Our models would certainly
slow down when the number of network parameters grew due to either the increase of grid size or the
increase of the number of digital capsules (i.e. the number of bits of 2D fingerprints). Results from a
simple test (Table 1) shows additional non-trivial time costs when more complex models used, e.g.
MACCSKey-b166-GS64-W5 and ECFP4-b1024-GS50-W5, which retarded further training with other
6
super parameters, e.g. ECFP4-b1024-GS64-W5. All in all, three out of five models were retained
to conduct the next evaluation task, namely MACCSKey-b166-GS50-W5, MACCSKey-b166-GS64-
W5, and ECFP4-b1024-GS50-W5, which were referred to as TF3P-50, TF3P-64, and TF3P-1024,
respectively.
Table 1. Time costs of training and inference for models with different super parameters.
Model’s Super-parameters Training
Timea (days)
Inference
Ratesb
(mols/min)
2D Fingerprint No. of Bits Grid Size Reconstruction
Weight
MACCSKey 166 50 0.005 ~ 7 ~ 6300
MACCSKey 166 50 1 ~ 7 ~ 6300
MACCSKey 166 64 0.005 ~ 10 ~ 3900
ECFP4 166 50 0.005 ~ 7 ~ 6300
ECFP4 1024 50 0.005 ~ 10 ~ 3700
a: 1% proportion of the full dataset over 10 epochs on three NVIDIA TITAN RTX GPUs. b: Random
samples from ChEMBL on one NVIDIA GeForce 2080 Ti GPU.
Capturing 3D structural changes of molecules
The basic virtue of 3D fingerprint is the capability to discriminate different conformers of a molecule.
To assess fingerprints’ ability to capture conformational changes, we sampled 1000 molecules with
the number of rotatable bonds ranging from 0 to 15 (This range was determined by the distribution
of the number of rotatable bonds in ChEMBL25, Figure S2). The RMSD values and similarity by
fingerprints between different conformers of each molecule were calculated. As the number of rotatable
bonds increases, the overall RMSD rises, denoting the growing conformational space of molecule
(Figure 4). 2D fingerprints unable to encode 3D conformational information produce similarity
values of one for all entries. Similarities by three versions of TF3P demonstrated comparably strong
correlations with RMSD, measured by Pearson’s r coefficients (-0.71 ~ -0.72) (Figure 4 and Table
S1). E3FP, USR, and USRCAT do have the ability to apprehend 3D conformational changes but
yield lower coefficients than TF3P. Taken together, TF3P is a better predictor, i.e. more sensitive, to
the actual 3D structural changes because TF3P can provide similarity rankings in better accordance
with the 3D structural changes, which is actually we need when quantifying chemical similarity,
despite the fact that TF3P yields generally higher similarity values. In addition, it is unreasonable
that some pairs of conformers with pretty low RMSD (< 1.0 Å) yield low similarities by E3FP (Down
left points in Figure 4 D, a typical example shown in Figure S3).
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Figure 4. The correlation between RMSD and similarity by TF3P-50 (A), TF3P-64 (B), TF3P-1024
(C), E3FP (D), USR (E), and USRCAT (F). Each point represents a pair of conformers belonging to
a molecule, colored by its number of rotatable bonds. The density plots are colored in the same way.
TF3P-50, TF3P-64, and TF3P-1024 refer to MACCSKey-b166-GS50-W5, MACCSKey-b166-GS64-
W5, and ECFP4-b1024-GS50-W5, respectively.
Two examples illustrated what discussed above. CHEMBL4116653 can undergo conformational
isomerization because of its freely rotatable single bonds (Figure 5 A). Among three conformers of
CHEMBL4116653, conf_1 is very similar to conf_3 but far dissimilar to conf_2, indicated by
the divergence in RMSD values (1.89 Å vs. 6.63 Å). The similarities by TF3P are consistent with
this divergence (0.88 vs. 0.52), but not by E3FP (0.28 vs. 0.28). Another case is a series of natural
products with four chiral carbons56, a pair of enantiomers plus a structural isomer (Figure 5 B).
2D fingerprints encounter bafflement when distinguishing between a pair of enantiomers, Anti-hh
and Anti-hh’, indicated by the similarities of one. Since they are isomers, the RMSD values among
them can be also calculated to indicate the 3D conformational deviation (2.89 Å vs. 3.81 Å, for
Anti-hh & Anti-hh’ and Anti-hh & Anti-ht, respectively). Similar situations occur for TF3P and
E3FP, respectively: The similarity by E3FP hardly changes (0.30 vs. 0.29), whereas the similarity
by TF3P shifts accordingly with the RMSD (0.78 vs. 0.73). Besides, there are also counter examples
where TF3P failed to capture some important conformational changes. As shown in Figure 5 C,
CHEMBL1789181 undergoes conformational isomerization with part of the structure flipped over,
the aromatic ring moiety and the aliphatic chain moiety swapping position with each other. Unlike
USRCAT and E3FP, TF3P showed its deficiency in apprehending this kind of change.
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Figure 5. A, B) Two promising examples with RMSD, similarities, 2D structures and 3D aligned
conformers. C) One counter example with RMSD, similarities, 2D structures and 3D aligned
conformers. TF3P here refers to TF3P-50.
Finding similar pockets by similar ligands
The primary intuition of using molecular 3D force fields grids has two aspects. On the one hand, force
fields contain the raw information dominating the interaction between drugs and targets; on the other
hand, force fields are degenerate of atom types and bonds of molecular graph representation. TF3P,
as a fingerprint derived from force fields, therefore, was expected to be capable to recognize molecule
pairs that are dissimilar in 2D topology but resemble each other in 3D shape and electrostatics.
Given the 3D complementation between the ligands and the pockets they bind to, this is deemed
to improve the precision of the targets similarity inference based on ligands similarity, which is the
essence of similarity-based target prediction. In this study, targets similarity was represented by
FuzCav pockets similarity57, with particular emphasis on the binding. PDBbind v2018 General
Set was selected to study the inference further with three situations (i.e. X2X, LE2X, and Flex)
evaluated to meet the concerns on conformation generation, as mentioned previously in Methods &
Materials. Given the time costs and performances discussed before, we only included TF3P-50 out of
three models in this part and referred to as simply as TF3P.
As shown in Table 2, the overall (Top 100%) Pearson’s r coefficients of FuzCav similarity vs.
the similarity by all fingerprints in all situations are low (0.08-0.20), suggesting the toughness to
perfectly infer target similarity from only ligands information. Nevertheless, it is noteworthy that the
correlations are generally higher in top-ranked samples by similarity than bottom-ranked ones with no
exception. The same trend occurs in Spearman’s rho (Table 3) and Kendall’s tau coefficients (Table
4). This probably results from that subtle differences between similar ligands correspond to a similar
degree of conformational changes between pockets and thus presenting correlations easy to fit for
top-ranked pairs by fingerprints similarity. However, in contrast to similar ligands binding to pockets
alike, every ligand dissimilar to others binds to its target in its own way, causing complications to the
regression for dissimilar pairs. As for top-ranked pairs, good correlations only mean similar orders
in two arrays of samples, not the exact values. We further analyzed the average values of FuzCav
similarities of samples with incrementing ranking thresholds. As shown in Figure 6, top-ranked
pairs by TF3P similarity present significantly higher average FuzCav pocket similarities than those
by USRCAT, E3FP and 2D fingerprints under the same situation. Taken together, compared to other
fingerprints, similar ligands found by TF3P do bind to similar targets and their ligand similarity is a
better indicator of the pocket similarity.
Table 2. Pearson correlation coefficients of FuzCav similarity vs. different fingerprints similarity for
all active pairs from PDBbind v2018 General Set.
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Top
%a
X2Xb LE2Xc Flexd MACCS
Key ECFP4TF3P E3FP USR
CAT
TF3P E3FP USR
CAT
TF3P E3FP USR
CAT
ROCS-
Combo
0.5 0.52* 0.29 0.40 0.24 0.19 0.22 0.36 0.24 0.30 0.37 0.34 0.31
1 0.47* 0.30 0.36 0.22 0.21 0.19 0.32 0.26 0.27 0.37 0.32 0.29
5 0.24 0.25 0.25 0.12 0.20 0.13 0.15 0.23 0.18 0.27* 0.20 0.24
10 0.17 0.22 0.21 0.08 0.17 0.11 0.10 0.21 0.16 0.23* 0.14 0.21
20 0.12 0.19* 0.18 0.06 0.15 0.11 0.08 0.18 0.14 0.18 0.10 0.18
50 0.07 0.15 0.15 0.06 0.13 0.11 0.06 0.15 0.13 0.17* 0.08 0.14
100 0.08 0.13 0.17 0.08 0.12 0.15 0.09 0.13 0.15 0.20* 0.10 0.11
a: Sorted by the indicated fingerprint similarity. b: Co-crystallized conformation aligned to co-
crystallized conformation. c: Low-energy conformation aligned to co-crystallized conformation. d:
Flexibly aligned to co-crystallized conformation.
Table 3. Spearman rank correlation coefficients of FuzCav similarity vs. different fingerprints
similarity for all active pairs from PDBbind v2018 General Set.
Top
%a
X2Xb LE2Xc Flexd MACCS
Key ECFP4TF3P E3FP USR
CAT
TF3P E3FP USR
CAT
TF3P E3FP USR
CAT
ROCS-
Combo
0.5 0.33* 0.16 0.13 0.14 0.12 0.06 0.21 0.15 0.10 0.20 0.18 0.19
1 0.20* 0.12 0.08 0.08 0.10 0.04 0.12 0.11 0.06 0.14 0.12 0.11
5 -0.01 0.08* 0.07 -0.04 0.07 0.05 -0.04 0.08* 0.06 0.06 0.01 0.03
10 -0.03 0.07 0.08* -0.05 0.07 0.05 -0.05 0.08* 0.07 0.05 0.00 0.02
20 -0.03 0.07 0.08* -0.03 0.07 0.06 -0.03 0.08* 0.07 0.06 0.01 0.01
50 -0.00 0.07 0.09 0.00 0.07 0.07 0.01 0.08 0.08 0.11* 0.03 0.02
100 0.04 0.08 0.13 0.05 0.08 0.13 0.01 0.09 0.12 0.20* 0.08 0.04
a: Sorted by the indicated fingerprint similarity. b: Co-crystallized conformation aligned to co-
crystallized conformation. c: Low-energy conformation aligned to co-crystallized conformation. d:
Flexibly aligned to co-crystallized conformation.
Table 4. Kendall rank correlation coefficients of FuzCav similarity vs. different fingerprints similarity
for all active pairs from PDBbind v2018 General Set.
Top
%a
X2Xb LE2Xc Flexd MACCS
Key ECFP4TF3P E3FP USR
CAT
TF3P E3FP USR
CAT
TF3P E3FP USR
CAT
ROCS-
Combo
0.5 0.22* 0.11 0.08 0.09 0.08 0.04 0.14 0.10 0.07 0.13 0.12 0.12
1 0.13* 0.08 0.05 0.05 0.07 0.02 0.08 0.08 0.04 0.09 0.08 0.08
5 -0.01 0.05* 0.04 -0.03 0.05* 0.03 -0.03 0.05* 0.04 0.04 0.01 0.02
10 -0.02 0.05* 0.05* -0.03 0.04 0.04 -0.03 0.05* 0.05* 0.03 0.00 0.01
20 -0.02 0.05 0.06* -0.02 0.04 0.04 -0.02 0.05 0.05 0.04 0.01 0.01
50 -0.00 0.05 0.06 0.00 0.04 0.05 0.01 0.05 0.05 0.08* 0.02 0.01
100 0.03 0.05 0.09 0.04 0.05 0.09 0.04 0.06 0.08 0.13* 0.05 0.03
a: Sorted by the indicated fingerprint similarity. b: Co-crystallized conformation aligned to co-
crystallized conformation. c: Low-energy conformation aligned to co-crystallized conformation. d:
Flexibly aligned to co-crystallized conformation.
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Figure 6. Average pocket similarity for samples with incrementing cutoffs in ranking (Top 1% is
equivalent to top 105).
In fact, we only pay attention to top-ranked outputs in the real scenarios of ligand-based drug
discovery. Like the early-stage enrichment is of vital importance for virtual screening, we also need a
stronger “early-stage enrichment” for target prediction based on only ligands similarity. This is to
say, a good fingerprint for ligand-based target prediction need have the ability to rank the targets
whose pockets are similar to the true target in the top of the targets pool and with an order that is
well correlated to their pockets similarity. To this end, TF3P outperforms the existing 3D and 2D
fingerprints, indicated by the higher average FuzCav similarities and higher correlations coefficients
under all three situations in top 1% shown in Table 2, 3, and 4, and Figure 6. This is not that
mention that TF3P-LE2X can achieve comparable results with all fingerprints under Flex situation
(Figure 6).
Additionally, another noteworthy point is that the correlation for top ranked ones can be gener-
ally ranked as: X2X > Flex > LE2X. This is of great significance because many reported that
2D fingerprints outperformed 3D descriptors under the condition of using generated low-energy
conformers58, 59. Our results suggest that those barely satisfactory performance of 3D fingerprints
are likely to be attributed to not use co-crystallized conformer (i.e. bioactive conformer), which urges
more endeavors to develop new computational tools meeting this demand.
Here, we also show three promising examples among the most similar pairs by TF3P that are not
alike by other fingerprints (Figure 7 A, B, and C), and one counter example (Figure 7 D). Each
pair binds to the same target. As the similarity values calculated by different fingerprints over the
same dataset show divergent distributions (Figure S4), the percentile ranks were computed and
attached below the exact values of similarity to demonstrate how similar different fingerprints regard
them. As shown in the aligned crystal structures (Figure 7 A, B, and C), all three pairs have
obviously similar 3D force fields but dissimilar in 2D topology. This leads to the difficulty to recognize
their resemblance for the existing fingerprints based on topological structure but not for TF3P that is
derived from 3D force fields. Therefore, T3FP can rank these pairs at the top places (Top 1%) based
on ligands similarity but others cannot. However, TF3P can miss under some circumstances. Figure
7 D shows a typical case where two ligands bind to the same target but have distinct structures.
Since the multi-benzene moiety and the aliphatic chain both serve as spacer, only the shape of the
spacer counts here but not the charges, providing a possible explanation for the behavior of TF3P
that is based on both vdW potential and electrostatic potential.
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Figure 7. A, B, C) Three top-ranked similar pairs by TF3P but are inaccessible by other fingerprints.
In terms of receptors, GluA2 for 4O3B and 5NG9, Protein Tyrosine Phosphatase 1B for 2CMB
and 2CNE, HIV-1 Protease for 2WKZ and 1B6K. D) One counter example TF3P yielded divergent
results against FuzCav. Human carbonic anhydrase II for 5E2R and 3IBL.
SEA analysis of PDBbind database
SEA is a widely used statistical model that quantitatively groups and relates proteins based on the
chemical similarity of their ligands. We utilized SEA to analyze all targets that annotated no less
than 10 active complexes within PDBbind v2018 General Set with five fingerprints, namely TF3P,
USRCAT, E3FP, MACCSKey and ECFP4. The results demonstrate a similar trend as the above
study: TF3P can enrich more pairs of the targets that resemble each other by pocket similarity in
the targets pool (Figure 8 A), yielding higher average FuzCav similarity in top-ranked pairs. This
indicates TF3P as a better choice for SEA-based target prediction, compared to other fingerprints.
One primary application of SEA is to cluster proteins using only ligands similarity to find some links
unexpected. First, it is not beyond anticipation that TF3P outputs a clustering of targets closer
to FuzCav similarity, measured by adjusted Rand score (Figure 8 B; for specific explanation of
adjusted Rand score, see Supplementary File 1). Moreover, some interesting links indeed emerged
when we conducted SEA analysis with TF3P (Figure 8 C). The first one is a cluster of HIV
relevant proteins, including HIV protease, HIV integrase, and HIV reverse transcriptase, which are
highly pharmacologically related. The second one is endothiapepsin (Uniprot ID: P11838) from
Cryphonectria parasitica and plasmepsin-2 (Uniprot ID: P46925) from Plasmodium falciparum, which
function similarly as aspartic-type endopeptidase although they are from different organisms. The
third one is a pair of nuclear receptors, retinoic acid receptor RXR-alpha (Uniprot ID: P19793)
and peroxisome proliferator-activated receptor gamma (Uniprot ID: P37231), which are not only
biologically related but also have a very conserved 3D structure of the ligand binding domain (Figure
8 D). Notably, the latter two did not emerge when using other four fingerprints (Figure S5).
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Figure 8. SEA analysis of the PDBbind database. A) Average pocket similarity for targets pairs
with incrementing cutoffs in the ranking. B) The distance of FuzCav clustering of targets to clustering
by five fingerprints, measured by adjusted Rand score. Higher means closer. C) Heatmap of E-value
of indicated targets calculated by SEA. Each point is colored by its E-value with lower values as
green and higher as yellow. For high-resolution images, see Supplementary File 2. D) Aligned crystal
structures of ligand binding domains of two indicated targets.
Application with machine learning models
Aside from calculating the similarity between two molecules, another important application of
fingerprints is to be used as the inputs for machine learning models. To this end, we used a very
simple model, single linear layer neural network (i.e. linear regression), to demonstrate TF3P’s
compatibility and performance on several tasks. TF3P achieves the lowest MSE value in 5-fold
cross-validation among all of the five fingerprints on solubility prediction and outperforms other 3D
fingerprints on malaria bioactivity prediction (Table 5), making itself a promising alternative when
integrated with machine learning models.
Table 5. Prediction of solubility and malaria bioactivity with different fingerprints.
Fingerprint
Solubility a
log10 (mol/L)
Malaria bioactivity a
ln (µmol/L)
MACCSKey + Linear layer 1.33 ± 0.20 1.22 ± 0.03
ECFP4 + Linear layer 1.71 ± 0.27 1.14 ± 0.03*
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Fingerprint
Solubility a
log10 (mol/L)
Malaria bioactivity a
ln (µmol/L)
E3FP + Linear layer 1.71 ± 0.27 1.34 ± 0.06
USRCAT + Linear layer 1.08 ± 0.14 1.40 ± 0.03
TF3P + Linear layer 0.66 ± 0.09* 1.27 ± 0.08
a: Evaluation matrix: mean ± std. of MSE
Conclusion
In summary, we developed a new fingerprint of 3D molecule with the deep capsular network, which
learned to encode the 3D force fields information into each digit of 2D fingerprint without labeled
data for specific predictive tasks. Ligands similarity can be intuitively calculated with the fingerprint
produced by our model, TF3P, and thus making it compatible with statistical models. Also, TF3P
could be applied with machine learning models as the inputs and present promising results. Since
TF3P is derived from molecular 3D force fields, it demonstrated its ability to recognize molecule
pairs that are dissimilar in 2D topology but resemble each other in 3D shape and electrostatics,
which improves its ability to infer pockets similarity based on only ligands similarity, detecting
pairs of ligands with similar targets inaccessible by other fingerprints. TF3P is anticipated to be a
better choice of fingerprints for ligand-based drug discovery in the future. Further development and
benchmarking studies of TF3P-based target prediction software are still going on.
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